eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. eLetters are not edited, proofread, or indexed. Please read our Terms of Service before submitting your own eLetter.
Research ArticleALLERGY
Platelets expressing IgG receptor FcγRIIA/CD32A determine the severity of experimental anaphylaxis
- View ORCID ProfileHéloïse Beutier1,2,3,*,
- View ORCID ProfileBéatrice Hechler4,*,
- View ORCID ProfileOphélie Godon1,2,
- View ORCID ProfileYu Wang1,2,5,
- Caitlin M. Gillis1,2,3,
- View ORCID ProfileLuc de Chaisemartin6,7,
- Aurélie Gouel-Chéron1,2,8,
- Stéphanie Magnenat4,
- Lynn E. Macdonald9,
- View ORCID ProfileAndrew J. Murphy9,
- NASA study group†,
- Sylvie Chollet-Martin6,7,
- Dan Longrois8,10,
- Christian Gachet4,
- Pierre Bruhns1,2,‡ and
- Friederike Jönsson1,2,‡
- 1Institut Pasteur, Department of Immunology, Unit of Antibodies in Therapy and Pathology, Paris, France.
- 2INSERM U1222, Paris, France.
- 3Université Pierre et Marie Curie, Paris, France.
- 4Université de Strasbourg, INSERM, Etablissement Français du Sang (EFS) Grand Est, Biologie et Pharmacologie des plaquettes sanguines (BPPS) UMR_S1255, Fédération de Médecine Translationnelle de Strasbourg (FMTS), F-67000 Strasbourg, France.
- 5Université Diderot Paris VII, Paris, France.
- 6Unité Fonctionnelle Auto-immunité et Hypersensibilités, Hôpital Bichat, Assistance Publique–Hôpitaux de Paris (AP-HP), Paris, France.
- 7UMR996—Inflammation, Chemokines et Immunopathology, INSERM, Université Paris-Sud, Université Paris-Saclay, Châtenay-Malabry, France.
- 8Département d’Anesthésie-Réanimation, Hôpital Bichat, AP-HP, Paris, France.
- 9Regeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA.
- 10INSERM UMR1152, Université Paris Diderot Paris 7, Paris, France.
- ↵‡Corresponding author. Email: joensson{at}pasteur.fr (F.J.); bruhns{at}pasteur.fr (P.B.)
↵* These authors contributed equally to this work.
See allHide authors and affiliations
Science Immunology 13 Apr 2018:
Vol. 3, Issue 22, eaan5997
DOI: 10.1126/sciimmunol.aan5997
Vol. 3, Issue 22, eaan5997
DOI: 10.1126/sciimmunol.aan5997
Héloïse Beutier
1Institut Pasteur, Department of Immunology, Unit of Antibodies in Therapy and Pathology, Paris, France.
2INSERM U1222, Paris, France.
3Université Pierre et Marie Curie, Paris, France.
Béatrice Hechler
4Université de Strasbourg, INSERM, Etablissement Français du Sang (EFS) Grand Est, Biologie et Pharmacologie des plaquettes sanguines (BPPS) UMR_S1255, Fédération de Médecine Translationnelle de Strasbourg (FMTS), F-67000 Strasbourg, France.
Ophélie Godon
1Institut Pasteur, Department of Immunology, Unit of Antibodies in Therapy and Pathology, Paris, France.
2INSERM U1222, Paris, France.
Yu Wang
1Institut Pasteur, Department of Immunology, Unit of Antibodies in Therapy and Pathology, Paris, France.
2INSERM U1222, Paris, France.
5Université Diderot Paris VII, Paris, France.
Caitlin M. Gillis
1Institut Pasteur, Department of Immunology, Unit of Antibodies in Therapy and Pathology, Paris, France.
2INSERM U1222, Paris, France.
3Université Pierre et Marie Curie, Paris, France.
Luc de Chaisemartin
6Unité Fonctionnelle Auto-immunité et Hypersensibilités, Hôpital Bichat, Assistance Publique–Hôpitaux de Paris (AP-HP), Paris, France.
7UMR996—Inflammation, Chemokines et Immunopathology, INSERM, Université Paris-Sud, Université Paris-Saclay, Châtenay-Malabry, France.
Aurélie Gouel-Chéron
1Institut Pasteur, Department of Immunology, Unit of Antibodies in Therapy and Pathology, Paris, France.
2INSERM U1222, Paris, France.
8Département d’Anesthésie-Réanimation, Hôpital Bichat, AP-HP, Paris, France.
Stéphanie Magnenat
4Université de Strasbourg, INSERM, Etablissement Français du Sang (EFS) Grand Est, Biologie et Pharmacologie des plaquettes sanguines (BPPS) UMR_S1255, Fédération de Médecine Translationnelle de Strasbourg (FMTS), F-67000 Strasbourg, France.
Lynn E. Macdonald
9Regeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA.
Andrew J. Murphy
9Regeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA.
Sylvie Chollet-Martin
6Unité Fonctionnelle Auto-immunité et Hypersensibilités, Hôpital Bichat, Assistance Publique–Hôpitaux de Paris (AP-HP), Paris, France.
7UMR996—Inflammation, Chemokines et Immunopathology, INSERM, Université Paris-Sud, Université Paris-Saclay, Châtenay-Malabry, France.
Dan Longrois
8Département d’Anesthésie-Réanimation, Hôpital Bichat, AP-HP, Paris, France.
10INSERM UMR1152, Université Paris Diderot Paris 7, Paris, France.
Christian Gachet
4Université de Strasbourg, INSERM, Etablissement Français du Sang (EFS) Grand Est, Biologie et Pharmacologie des plaquettes sanguines (BPPS) UMR_S1255, Fédération de Médecine Translationnelle de Strasbourg (FMTS), F-67000 Strasbourg, France.
Pierre Bruhns
1Institut Pasteur, Department of Immunology, Unit of Antibodies in Therapy and Pathology, Paris, France.
2INSERM U1222, Paris, France.
Friederike Jönsson
1Institut Pasteur, Department of Immunology, Unit of Antibodies in Therapy and Pathology, Paris, France.
2INSERM U1222, Paris, France.
Submit a Response to This Article
No eLetters have been published for this article.